TrialEpilepsia open2024

Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double-blind placebo-controlled crossover trial.

Arjune Sen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.